Net SIP inflow data is not comparable with gross figures, says Amfi

Net SIP inflow data is not comparable with gross figures, says Amfi



The net systematic investment plan (SIP) inflow data is not comparable with the gross SIP inflow data, the Association of Mutual Funds in India (Amfi) said on Friday.


While gross SIP inflows are the total inflows accumulated by mutual funds from SIP investors during the month, the net SIP inflow is adjusted for the redemptions from SIP accounts during the month.


In a media call, Venkat Chalasani, chief executive, Amfi, said that since the redeemed units were accumulated over several months or years, the net SIP inflows are not comparable with the gross inflows, which show the total SIP investments only for that particular month.


The clarification came following media reports of stagnant net inflows even as gross SIP inflows continue to rise. In July, the gross SIP inflow was Rs 23,332 crore, while the net SIP inflow was Rs 8,964 crore.


On an aggregate basis (including both SIP and lump sum), equity mutual fund (MF) schemes raked in a gross sum of Rs 81,158 crore in July. After adjusting for Rs 44,045 crore in redemptions, the net inflows stood at Rs 37,113 crore.

First Published: Aug 23 2024 | 5:05 PM IST



Source link

Nifty above 24,800; VIX spurts 4.25%; auto shares rally

Nifty above 24,800; VIX spurts 4.25%; auto shares rally


The domestic equity benchmarks ended near the flatline with some positive bias on Friday. The Nifty settled above the 24,800 level. Barring the Nifty Auto index, all the other sectoral indices on the NSE ended in red.

As per provisional closing, the barometer index, the S&P BSE Sensex, rose 33.02 points or 0.04% to 81,086.21. The Nifty 50 index added 11.65 points or 0.05% to 24,823.15.

In the broader market, the S&P BSE Mid-Cap index fell 0.66% and the S&P BSE Small-Cap index added 0.15 %.

The market breadth was positive. On the BSE, 2,063 shares rose and 1,873 shares fell. A total of 112 shares were unchanged.

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, rallied 4.25% to 13.55.

IPO Update :

The initial public offer (IPO) of Orient Technologies received 1,06,10,57,592 bids for shares as against 74,49,846 shares on offer, according to stock exchange data at 13:20 IST on Friday (21 August 2024). The issue was subscribed 142.43 times.

The issue opened for bidding on Wednesday (21 August 2024) and it will close on Friday (23 August 2024). The price band of the IPO is fixed between Rs 195 to Rs 206 per share. An investor can bid for a minimum of 72 equity shares and in multiples thereof.

Buzzing Index:

The Nifty Auto index added 1.07% to 25,836.40. The index shed 0.09% in the past trading session.

Bajaj Auto (up 4.92%), TVS Motor Company (up 2.17%), Tata Motors-DVR (up 2%), Samvardhana Motherson International (up 1.94%), Tata Motors (up 1.64%), Hero MotoCorp (up 0.97%), Mahindra & Mahindra (up 0.95%), Bosch (up 0.34%), Apollo Tyres (up 0.33%) and Maruti Suzuki India (up 0.21%) edged higher.

On the other hand, Exide Industries (down 2.6%), MRF (down 0.78%) and Eicher Motors (down 0.77%) edged lower.

Stocks in Spotlight:

Adani Power (APL) rose 0.19%. The company said that it has received an approval from the National Company Law Tribunal (NCLT) Hyderabad Bench to acquire 100% stake in Lanco Amarkantak Power (LAPL).

Sun Pharmaceutical Industries advanced 1.39% fter the company announced that it has launched Tedizolid Phosphate tablets in India under the brand name Starizo.

RailTel Corporation of India jumped 5.81% after the company informed that it has received a work order worth Rs 52.66 crore from Uttar Pradesh Police Recruitment and Promotion Board for providing various services.

JSW Energy fell 1.08%. The company said that its wholly owned subsidiary JSW Neo Energy has received letter of award (LoA) for setting up 300 MW ISTS-connected Wind-Solar Hybrid Power Project from NTPC.

Jain Irrigation Systems zoomed 11% after the company signed memorandum of association of Coffee Board of India for the commercial release of high quality, disease-resistant coffee plants to growers.

Jindal Saw rose 0.29%. The companys board has approved the sub division of every two equity share of face value of Rs 2 each into one equity shares having face value of Re 1 each.

Poly Medicure added 3.47% after the company said that it has raised Rs 1,000 crore by way of issue of qualified institutional placement (QIP).

Prism Johnson rallied 3.87% after the company announced that it has entered into a shareholders agreement for acquiring 50% of the issued and paid-up capital of Sunbath Sanitary.

Global Markets:

Europeans market advanced while Asian stocks ended lower on Friday as investors anticipated comments from Jerome Powell later on Friday.

The yen strengthened early Friday after Japanese inflation data surpassed expectations. Government figures revealed that core CPI, which excludes volatile fresh food prices, rose 2.7% year-over-year in July, while headline CPI inflation increased by 2.8% during the same period.

U.S. stocks declined on Thursday, with the S&P 500 falling 0.89% and the tech-heavy Nasdaq 100 dropping 1.67%. The Dow Jones also decreased by 0.43%. Nvidia Corp. led losses in the tech sector with a sharp 3.7% drop, while Intel Corp. fell by 6.1%. Conversely, bank stocks rose, and energy shares gained alongside rising oil prices. Notably, Peloton Interactive Inc. soared 35% after reporting earnings that exceeded estimates.

Fed Chair Powell is scheduled to speak at the Jackson Hole Symposium on Friday, where he is expected to provide further insights into the central banks plans for potential interest rate cuts.

New jobless claims in the U.S. increased slightly last week but remained relatively low, suggesting a gradual slowdown in the labor market. This trend could pave the way for the Federal Reserve to begin lowering interest rates next month. Initial claims for state unemployment benefits rose by 4,000 to a seasonally adjusted 232,000 for the week ended August 17, according to the Department of Labor.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 23 2024 | 3:47 PM IST



Source link

Sun Pharma hits 52-week high on launch of skin infection drug 'Starizo'

Sun Pharma hits 52-week high on launch of skin infection drug 'Starizo'


Sun Pharma stock hits 52-week high: Shares of pharmaceutical company Sun Pharma rose as much as 1.76 per cent to hit a fresh 52-week high of Rs 1,781.55 per share on Friday, August 23, 2024. 


The rally in the stock price of Sun Pharma came after the company announced the launch of Starzio (Tedizolid Phosphate) in India for Acute Bacterial Skin and Skin Structure Infections (ABSSSI).


In an exchange filing, Sun Pharma said, “Sun Pharma and its subsidiaries and/or associate companies) today announced that it has launched Tedizolid Phosphate tablets 200 mg in India under the brand name ‘Starzio’.”


Starzio, an oxazolidinone-class antibiotic, is designed to treat ABSSSI with a once-daily oral regimen for six days. This contrasts with the conventional treatment, which requires twice-daily dosing over 10-14 days. Starzio is effective against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and offers advantages such as reduced dosing frequency and no dose adjustment needed for elderly patients or those with liver or kidney impairments.


“Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) causing ABSSSIs, are more challenging to treat due to the limited availability of effective treatment options in hospitals. With STARIZO, we are introducing a treatment option which is effective and has the convenience of once-a-day dosing”, said Kirti Ganorkar, CEO of India business at Sun Pharma.


Also, skin and soft tissue infections are prevalent in India, accounting for approximately 29-32 per cent of all infections in 2018-2019, often complicated by comorbidities like diabetes and renal or hepatic dysfunction.


The company further said that it has secured rights from MSD to develop, manufacture, and market Tedizolid Phosphate in India, under a licencing agreement with Merck Sharp & Dohme Singapore Trading Pte. Ltd.


Sun Pharmaceutical Industries Limited, commonly known as Sun Pharma, is a Mumbai-based multinational pharmaceutical company. It is the largest pharmaceutical company in India.It operates globally with a strong presence in markets like the United States, India, Europe, and others.


The company specialises in manufacturing and marketing a wide range of pharmaceutical formulations in various therapeutic areas such as psychiatry, neurology, cardiology, orthopaedics, ophthalmology, dermatology, gastroenterology, and oncology, among others.


The market capitalisation of Sun Pharma is Rs 4,20,015.51 crore, according to Bombay Stock Exchange (BSE). The 52-week low of the stock is Rs 1,069 per share.


At 2:39 PM, shares of Sun Pharma were trading 1.45 per cent higher at Rs 1776 per share. In comparison, BSE Sensex was trading 0.07 per cent higher at 81,112.27 levels.

First Published: Aug 23 2024 | 2:47 PM IST



Source link

Axis Securities recommends buying these 4 stocks from metals & mining space

Axis Securities recommends buying these 4 stocks from metals & mining space


Stocks to buy, Hindalco, Coal India, APL Pollo Tubes


Axis Securities has recommended four stocks with a ‘Buy’ rating from the metals and mining space, following their Q1FY25 results.


In a research note, Axis Securities that steel and non-ferrous companies across the metals and mining segment saw an improvement in earnings before interest tax depreciation and amortisation per ton (EBITDA/t) led by lower coal costs in the first quarter of financial year 2024-25, which offset these companies’ lower operating leverage.


Looking ahead, the brokerage firm expects steel spreads to come under pressure in Q2FY25, which will impact companies operating in the steel space. Here is a list of stocks recommended by Axis Securities:


Hindalco Industries


The brokerage has given a ‘buy’ rating on Hindalco’s stock, with a target price of Rs 715 per share.


The company’s expansion projects, such as the 600 kt Bay Minette (by H2CY26), Copper Inner Grooved Tubes (end of CY24) and downstream Aluminium projects (end of FY26), will lead to an increase in the EBITDA/t from FY27 onwards, as the projects get commissioned and start contributing fully from FY27, the brokerage noted.


While talking about Novelis, a subsidiary of Hindalco, the brokerage firm highlighted the company’s management’s guidance  of $525 per tonne EBITDA/t on a sustainable basis.


It added that the company has multiple levers to achieve EBITDA/t towards $600 per tonne in the future.


Coal India


Axis Securities has given a ‘buy’ rating for Coal India’s stock, along with a target price of Rs 575.


Analysts at Axis Securities are upbeat on Coal India, considering the company’s ambitious coal production and off-take targets of of 838/1,000MT for FY25 and FY26.


Additionally, its implementation strategies for the development of coal evacuation infrastructure in the form of First Mile Connectivity (FMC) Projects, Rail projects, and other groundwork like land acquisition to achieve its production target of one billion tonnes by FY26, are also key positives.


Further, the company has a capex plan of Rs 15,500 crore for FY25, and it plans to allocate a significant portion of that towards diversification projects such as solar and thermal power, coal gasification and the revival of fertilizer plants, which are other positives for the mining behemoth.


APL Apollo Tubes


The brokerage has given a ‘buy’ rating on APL Apollo Tubes’ stock, with a target price of Rs 1,650. Axis Securities is bullish on the company’s capacity ramp-up ahead.


JTL Industries


Axis Securities has given a ‘buy’ call on JTL Industries, with a target price of Rs 260. The brokerage is optimistic about the company’s EBITDA/t growth strategy and capacity expansion.

First Published: Aug 23 2024 | 1:53 PM IST



Source link

Nifty above 24,800; VIX spurts 4.25%; auto shares rally

Benchmarks trade with minor gains; IT share slides


The key equity indices continued to trade with small gains in early afternoon trade. The Nifty traded above the 24,800 level. IT shares extended losses for the third consecutive trading session.

At 12:30 IST, the barometer index, the barometer index, the S&P BSE Sensex, rose 52.34 points or 0.06% to 81,103.10. The Nifty 50 index added 26.80 points or 0.11% to 24,838.30.

In the broader market, the S&P BSE Mid-Cap index fell 0.34% and the S&P BSE Small-Cap index rose 0.14%.

The market breadth was positive. On the BSE, 2,079 shares rose and 1,728 shares fell. A total of 134 shares were unchanged.

Derivatives:

The NSE’s India VIX, a gauge of the market’s expectation of volatility over the near term, shed 0.42% to 12.95. The Nifty 29 August 2024 futures were trading at 24,865.15, at a premium of 26.85 points as compared with the spot at 24,838.30.

The Nifty option chain for the 29 August 2024 expiry showed maximum Call OI of 65 lakh contracts at the 26,000 strike price. Maximum Put OI of 87.4 lakh contracts were seen at 24,000 strike price.

Buzzing Index:

The Nifty IT index rose 0.82% to 41,166.80. The index shed 0.97% in three consecutive trading sessions.

Mphasis (down 2.14%), Persistent Systems (down 1.35%), LTIMindtree (down 1.12%), Tech Mahindra (down 0.95%), Infosys (down 0.85%), Tata Consultancy Services (down 0.77%), Coforge (down 0.66%), Wipro (down 0.64%), HCL Technologies (down 0.57%) and L&T Technology Services (down 0.19%) declined.

Stocks in Spotlight :

Adani Power (APL) rose 0.58%. The company said that it has received an approval from the National Company Law Tribunal (NCLT) Hyderabad Bench to acquire 100% stake in Lanco Amarkantak Power (LAPL).

Shakti Pumps (India) added 1.02% after the company announced that it has received an order worth Rs 9.40 crore from Jharkhand Renewable Energy Development Agency for supply of 400 units of solar water pumping systems.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 23 2024 | 12:35 PM IST



Source link

ADAG stocks crack up to 7% as Sebi bans Anil Ambani from markets for 5 yrs

ADAG stocks crack up to 7% as Sebi bans Anil Ambani from markets for 5 yrs


Sebi has also imposed a penalty of Rs 25 crore on Ambani


Reliance ADAG stocks in focus: Shares of Anil Dhirubhai Ambani Group (ADAG) companies saw a sudden fall in their prices in Friday’s intraday trade. The decline came amid a report that market regulator Securities and Exchange Board of India (Sebi) has barred Anil Ambani from accessing capital markets for five years.


According to a PTI report, Sebi has barred Anil Ambani, and 24 other entities, from the securities market for a period of five years, to reprimand them for diversion of funds from the company.


Sebi has also imposed a penalty of Rs 25 crore on Ambani and restrained him from being associated with the securities market including as a director or Key Managerial Personnel (KMP) in any listed company, or any intermediary registered with the market regulator, for a period of 5 years, the report said.


It also barred Reliance Home Finance from the securities market for six months and imposed a fine of Rs 6 lakh.


Among individual stocks, Reliance Power share price fell 2.9 per cent (Rs 35.19 per share), Reliance Home Finance 4.9 per cent (Rs 4.46), and Reliance Infrastructure 6.9 per cent (Rs 219).


Trading in shares of Reliance Communications, Reliance Capital, and Reliance Naval and Engineering remains suspended. By comparison, the BSE benchmark Sensex index was up 108 points at 81,161 level at 11:40 AM.


Why did Sebi ban Anil Ambani from stock markets?


Sebi’s ban on Anil Ambani came after the regulator found that Ambani, with the help of Reliance Home Finance’s (RHFL’s) key managerial personnel, orchestrated a fraudulent scheme to siphon-off funds from RHFL by disguising them as loans to entities linked to him.


This happened even as the Board of Directors of RHFL issued strong orders to stop such lending practices.


“This suggests a significant failure of governance, driven by certain key managerial personnel under the influence of Anil Ambani. We believe the company RHFL itself should not be held equally responsible as the individuals involved in the fraud. Further, the remaining entities have played the role of being either recipients of illegally obtained loans or conduits to enable illegal diversion of monies from RHFL,” Sebi said in its 222-page report.

First Published: Aug 23 2024 | 11:47 AM IST



Source link

YouTube
Instagram
WhatsApp